GeneBio Systems
EIF4A3 Polyclonal Antibody
EIF4A3 Polyclonal Antibody
SKU:E-AB-18715
Couldn't load pickup availability
Size: 200μL
Storage: Store at -20℃ Valid for 12 months. Avoid freeze / thaw cycles.
Shipping: The product is shipped with ice pack,upon receipt,store it immediately at the temperature recommended.
Exp date: 12 months
Category ID_II: Primary Antibodies
Category ID_III: Polyclonal Antibodies
Abbreviation: EIF4A3
Target Synonym: ATP-dependent RNA helicase DDX48;ATP-dependent RNA helicase eIF4A-3;DDX48;DEAD box protein 48;eIF-4A-III;eIF4A-III;EIF4A3;eIF4AIII;Eukaryotic initiation factor 4A-III;Eukaryotic initiation factor 4A-like NUK-34;Eukaryotic translation initiation factor 4A isoform 3;hNMP 265;IF4A3;NMP 265;NMP265;Nuclear matrix protein 265;NUK34
Research Areas: Cancer;Epigenetics and Nuclear Signaling
Conjugation: Unconjugated
Host: Rabbit
Species reactivity: Human;Mouse;Rat
Application: WB;IHC
Isotype: IgG
Clonality: Polyclonal
Clone NO.:
UNIProt ID: P38919
Accession:
Background: This gene encodes a member of the DEAD box protein family. DEAD box proteins, characterized by the conserved motif Asp-Glu-Ala-Asp (DEAD), are putative RNA helicases. They are implicated in a number of cellular processes involving alteration of RNA secondary structure, such as translation initiation, nuclear and mitochondrial splicing, and ribosome and spliceosome assembly. Based on their distribution patterns, some members of this family are believed to be involved in embryogenesis, spermatogenesis, and cellular growth and division. The protein encoded by this gene is a nuclear matrix protein. Its amino acid sequence is highly similar to the amino acid sequences of the translation initiation factors eIF4AI and eIF4AII, two other members of the DEAD box protein family.
Concentration: 1.5 mg/mL
Immunogen: Fusion protein of human EIF4A3
Buffer: PBS with 0.05% NaN3 and 40% Glycerol,pH7.4
Purification method: Antigen affinity purification
Dilution: WB 1:500-1:2000;IHC 1:50-1:300
Calculated MW: 47 kDa
ObservedMW: Refer to figures
